Substance

RAVULIZUMAB

Global reference: every product and company linked to this substance.

ALXN-1210 · ALXN1210 · ravulizumab [INN] · RAVULIZUMAB [JAN] · RAVULIZUMAB [USAN] · Ravulizumab [WHO-DD]

Revenue by product (0)

No revenue reported for this substance in loaded filings.

A figure belongs to the product it was reported for. It is never summed across companies or across a company's products, so one substance in three products shows three figures.

Products containing this substance (0)

    Companies holding this asset (1)